373 related articles for article (PubMed ID: 8149362)
21. Human platelet MAO in drug-free and medicated schizophrenic patients.
Friedhoff AJ; Miller JC; Weisenfreund J
Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
[TBL] [Abstract][Full Text] [Related]
22. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
[TBL] [Abstract][Full Text] [Related]
23. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
[TBL] [Abstract][Full Text] [Related]
24. Platelet monoamine oxidase activity in underweight and weight-recovered females with anorexia nervosa.
Ehrlich S; Franke L; Schott R; Salbach-Andrae H; Pfeiffer E; Lehmkuhl U; Uebelhack R
Pharmacopsychiatry; 2008 Nov; 41(6):226-31. PubMed ID: 19067259
[TBL] [Abstract][Full Text] [Related]
25. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels.
Ertugrul A; Ucar G; Basar K; Demir B; Yabanoglu S; Ulug B
Psychiatry Res; 2007 Jan; 149(1-3):49-57. PubMed ID: 17157920
[TBL] [Abstract][Full Text] [Related]
26. [Decrease in the thrombocyte monoamine oxidase activity of schizophrenic patients].
Kurilova II; Lideman RR
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(9):1351-4. PubMed ID: 706910
[TBL] [Abstract][Full Text] [Related]
27. Poor outcome and low platelet MAO activity in chronic schizophrenia.
Bierer L; Docherty JP; Young JG; Giller E; Cohen D
Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
[TBL] [Abstract][Full Text] [Related]
28. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
[TBL] [Abstract][Full Text] [Related]
29. Platelet monoamine oxidase in chronic schizophrenic patients.
Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
[TBL] [Abstract][Full Text] [Related]
30. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia].
Smirnov AV; Prilipko LL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):76-8. PubMed ID: 3414255
[TBL] [Abstract][Full Text] [Related]
31. Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Que., Canada.
Stamler CJ; Abdelouahab N; Vanier C; Mergler D; Chan HM
Neurotoxicology; 2006 May; 27(3):429-36. PubMed ID: 16494947
[TBL] [Abstract][Full Text] [Related]
32. Platelet monoamine oxidase activity in schizophrenic patients.
Becker RE; Shaskan EG
Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
[TBL] [Abstract][Full Text] [Related]
33. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
Pivac N; Knezevic J; Kozaric-Kovacic D; Dezeljin M; Mustapic M; Rak D; Matijevic T; Pavelic J; Muck-Seler D
J Affect Disord; 2007 Nov; 103(1-3):131-8. PubMed ID: 17289152
[TBL] [Abstract][Full Text] [Related]
34. Decreased platelet monoamine oxidase activity in female anorexia nervosa.
Díaz-Marsá M; Carrasco JL; Hollander E; César J; Saiz-Ruiz J
Acta Psychiatr Scand; 2000 Mar; 101(3):226-30. PubMed ID: 10721871
[TBL] [Abstract][Full Text] [Related]
35. Blood platelet monoamine oxidase activity in psychiatric patients.
Friedman E; Shopsin B; Sathananthan G; Gershon S
Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
[No Abstract] [Full Text] [Related]
36. Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients.
Chojnacki M; Kralik P; Allen RH; Ho BT; Schoolar JC; Smith RC
Am J Psychiatry; 1981 Jun; 138(6):838-40. PubMed ID: 6113772
[No Abstract] [Full Text] [Related]
37. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
Mann J; Thomas KM
Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
[TBL] [Abstract][Full Text] [Related]
38. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
[TBL] [Abstract][Full Text] [Related]
39. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI
Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
[TBL] [Abstract][Full Text] [Related]
40. Tranylcypromine lowers human platelet MAO B activity but not concentration.
Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW
Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
